A NEW BREAKTHROUGH AGAINST CANCER
A NEW BREAKTHROUGH AGAINST CANCER Every so often, science hands us a miracle — not the kind wrapped in mystery, but the kind wrapped in data, clinical trials, and undeniable results. Such is the case with Dostarlimab , an experimental cancer drug that has stunned the global medical community. In clinical trials at Memorial Sloan Kettering Cancer Center in New York, 80% of patients with a specific type of rectal cancer were completely cured . No chemotherapy. No radiation. No surgery. No tumor left in follow-up scans. Let me repeat that: cured . So the questions practically jump out: When can we bring this technology here? How long should we wait before we start saving Filipino lives? And more painfully — how many of our kababayans will die while we delay its adoption? A Treatment That Lets the Body Do the Fighting Dostarlimab is not the typical “nuclear option” we associate with cancer therapy. It is immunotherapy — a smarter, targeted approach. It works by blocking the PD-1 protein...